Results 21 to 30 of about 18,976 (183)
Context Malignant mesothelioma is an insidious neoplasm, with malignant pleural mesothelioma as the most common type, which is characterized by poor prognosis in most patients owing to late presentation. The use of noninvasive markers for early diagnosis
Mona M Ahmed +3 more
doaj +1 more source
Role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma
Aim of the work: To evaluate the role of interleukin-6 (IL-6) in diagnosis of malignant pleural mesothelioma by detecting its level in the pleural fluid and serum of the patient with malignant pleural mesothelioma in comparison with other causes of ...
Rehab El Sayed +4 more
doaj +1 more source
Primary pleural mesothelioma [PDF]
In this series of nine patients with primary pleural mesothelioma, three patients, all women, had "localized benign" tumors located in the left chest, although one had a recurrence on the right. Five patients all male, had the "diffuse malignant" type, and one woman had "multiple discrete" pleural tumors. Classification on the basis of gross appearance
openaire +2 more sources
Diagnosis and treatment of pleural mesothelioma. State of the art 2024
Pleural mesothelioma is a cancer with a low incidence and poor prognosis. Treatment of pleural mesothelioma includes surgery, radiotherapy and systemic treatment — chemotherapy and immunotherapy. Tri-modal therapy, consisting of surgery, chemotherapy and
Zofia Lewandowska, Dariusz M. Kowalski
doaj +1 more source
Mesothelioma in situ is a recently described precursor to invasive mesothelioma. Thus far, all cases in the literature have involved one pleural cavity or the peritoneal cavity. We describe a patient with biopsy-proven mesothelioma in situ involving both
Alyssa MacLean, MD +2 more
doaj +1 more source
Immunotherapy in Malignant Pleural Mesothelioma [PDF]
The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without bevacizumab. Immunotherapy did seem active in small phase II trials. In this review, we will highlight the most important immunotherapy-based research performed and put a focus on the future of MPM. PD-
Gooijer, C.J. de +3 more
openaire +4 more sources
Pleural Mesothelioma With Unusual Squamous Differentiation: A Clinicopathological Case Report With Molecular Insights From Whole‐Exome Sequencing [PDF]
This case report highlights a rare histological variant of pleural mesothelioma with partially squamous differentiation in an 81‐year‐old man with occupational asbestos exposure. In addition to histological, immunohistochemical and fluorescence in situ hybridization analyses, indicating a common mesothelial origin of both tumor components, whole‐exome ...
Bodemeyer J +12 more
europepmc +2 more sources
Pleural mesothelioma with metastatic peritoneal involvement is an extremely rare finding. Very few cases are reported in the literature. We present a case of pleural mesothelioma referred for F-18-fluorodeoxyglucose positron emission tomography/computed ...
Anuja Anand +4 more
doaj +1 more source
Malignant mesothelioma is a fatal asbestos-associated malignancy originating from the lining cells (mesothelium) of the pleural and peritoneal cavities, as well as the pericardium and the tunica vaginalis.
Parker Robert J +2 more
doaj +1 more source
Malignant pleural mesothelioma
Malignant pleural mesothelioma G. L. Ceresoli, G. P. Betta, B. Castagneto, F. Facciolo, G. Arcangeli, P. A. Zucali, R. Libener, D. De Giovanni, E. Melis & M. A. Mirri Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano (MI); Pathology Unit, Department of Oncology, Azienda Sanitaria Ospedaliera, Alessandria ...
G L, Ceresoli +9 more
openaire +2 more sources

